Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bedtime insulin glargine or bedtime neutral protamine lispro combined with sulfonylurea and metformin in type 2 diabetes. A randomized, controlled trial

Trial Profile

Bedtime insulin glargine or bedtime neutral protamine lispro combined with sulfonylurea and metformin in type 2 diabetes. A randomized, controlled trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Aug 2017

At a glance

  • Drugs Insulin glargine (Primary) ; Insulin neutral protamine lispro (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Aug 2018 Biomarkers information updated
    • 21 Oct 2008 Results published in the Annals of Internal Medicine
    • 21 Oct 2008 Primary endpoint 'Proportion of glycosylated haemoglobin' has not been met based on results published in Annals of Internal Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top